Related Experiment Videos
Experimental animal models for anaerobic infections
Reviews of Infectious Diseases
|March 1, 1979
Summary
Chloramphenicol failed to treat sepsis in rats due to bacterial inactivation. Metronidazole, however, effectively reduced mortality in mixed aerobic-anaerobic infections, highlighting the importance of antimicrobial metabolism in vivo.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Intra-abdominal sepsis involves complex aerobic and anaerobic microflora.
- Antimicrobial efficacy can be influenced by bacterial metabolism in vivo.
- Previous studies showed limited success with chloramphenicol in an animal sepsis model.
Purpose of the Study:
- To investigate the efficacy of antimicrobials in a mixed aerobic-anaerobic sepsis model.
- To explore the mechanism behind chloramphenicol's reduced efficacy.
- To evaluate metronidazole's effectiveness against polymicrobial infections.
Main Methods:
- Developed an experimental animal model for intra-abdominal sepsis.
- Utilized in vitro cultures to study antimicrobial inactivation by bacteria.
- Assessed survival rates and bacterial levels in treated rats.
- Employed mixed continuous cultures to simulate polymicrobial environments.
Main Results:
- Chloramphenicol showed modest survival benefits, as it was inactivated by Bacteroides fragilis.
- Metronidazole reduced mortality in mixed infections, dependent on the presence of anaerobes.
- Metronidazole decreased Escherichia coli levels in mixed cultures with B. fragilis, but not in pure cultures or with clindamycin.
Conclusions:
- Bacterial metabolism significantly impacts antimicrobial efficacy in vivo.
- Metronidazole's effectiveness in polymicrobial infections is linked to its interaction with anaerobic bacteria.
- The site of infection and bacterial organotropism influence host response.